These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22170275)
21. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment. Sachs-Ericsson N; Blazer DG Aging Ment Health; 2015 Jan; 19(1):2-12. PubMed ID: 24914889 [TBL] [Abstract][Full Text] [Related]
22. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease. Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847 [TBL] [Abstract][Full Text] [Related]
23. Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease. Safarpour D; Willis AW Am J Alzheimers Dis Other Demen; 2016 Nov; 31(7):585-594. PubMed ID: 27295974 [TBL] [Abstract][Full Text] [Related]
24. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan. Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792 [TBL] [Abstract][Full Text] [Related]
31. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up. Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674 [TBL] [Abstract][Full Text] [Related]
32. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006 [TBL] [Abstract][Full Text] [Related]
33. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia. McCarter SJ; Stang C; Turcano P; Mielke MM; Ali F; Bower JH; Savica R Parkinsonism Relat Disord; 2020 Apr; 73():19-22. PubMed ID: 32203914 [TBL] [Abstract][Full Text] [Related]
34. Cognitive dysfunction and dementia in Parkinson disease. Caballol N; Martí MJ; Tolosa E Mov Disord; 2007 Sep; 22 Suppl 17():S358-66. PubMed ID: 18175397 [TBL] [Abstract][Full Text] [Related]
35. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease. Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744 [TBL] [Abstract][Full Text] [Related]
36. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Brodaty H; Heffernan M; Kochan NA; Draper B; Trollor JN; Reppermund S; Slavin MJ; Sachdev PS Alzheimers Dement; 2013 May; 9(3):310-317.e1. PubMed ID: 23110866 [TBL] [Abstract][Full Text] [Related]
37. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277 [TBL] [Abstract][Full Text] [Related]
38. Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia. Matteau E; Dupré N; Langlois M; Provencher P; Simard M J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):100-6. PubMed ID: 22689702 [TBL] [Abstract][Full Text] [Related]
39. Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults. Moon JH; Lim S; Han JW; Kim KM; Choi SH; Park KS; Kim KW; Jang HC Stroke; 2015 Apr; 46(4):1024-30. PubMed ID: 25737314 [TBL] [Abstract][Full Text] [Related]
40. Biomarkers of cognitive decline in Parkinson's disease. Lin CH; Wu RM Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]